Skip to content

Effectiveness of App-based Relaxation for Patients With Chronic Neck Pain

A Randomized Pragmatic Trial About the Effectiveness of an App Based Relaxation Technique for Patients With Chronic Neck Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02019134
Acronym
Relaxneck
Enrollment
220
Registered
2013-12-24
Start date
2014-03-31
Completion date
2017-02-28
Last updated
2017-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Neck Pain

Keywords

chronic neck pain, relaxation technique, comparative effectiveness research

Brief summary

The aim of the pragmatic randomized study is to evaluate whether additional relaxation technique is more effective in the reduction of chronic neck pain compared to usual care alone.

Detailed description

Objective: To evaluate whether additional relaxation technique is more effective in the reduction of chronic neck pain compared to usual care alone. Study design: Open single-centered randomized two-armed pragmatic trial. Participants: 220 patients aged 18-65 years with chronic (\>12 weeks) neck pain and a mean pain score ≥ 4 on a Numeric Rating scale (NRS) in the last week before randomization who will be randomly allocated to two groups (relaxation, usual care alone as waiting list) Intervention: Participants apply either a daily 15-minute relaxation exercise guided by a smartphone application (app). or apply no additional intervention. The exercise should be applied daily, (minimally, five days per week) for 6 months. The app contains audios to guide autogenic training, muscle relaxation training and guided imagery. On a daily basis, participants can select one of the three exercises which they want to apply. Main outcome measure: The primary outcome is the mean pain intensity after 3 months measured by the daily pain intensity on the NRS.

Interventions

relaxation exercise

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* female or male * 18-65 years of age * chronic neck pain for at least 12 weeks * if additional back pain is reported, neck pain has to be predominant * intensity of the average neck pain ≥ 4 on the numeric rating scale (NRS) in the last week * presence of a smartphone (iphone, Android phone) and willingness to do data entry through a smart phone application (App) * physical and mental ability to participate in the study * willingness to be randomized, to apply study intervention according to the protocol, to complete the baseline questionnaire in paper form and electronic questionnaires and diaries provided by a smart phone application * written and oral informed consent

Exclusion criteria

* neck pain caused by a known malignant disease * neck pain caused by trauma * known rheumatic disorder * history or planned surgery of the spinal column of the neck in the next 6 months * known neurological symptoms e.g radicular symptoms because of prolapsed vertebral disc * regular intake of analgesics (\>1x per week) because of additional diseases * intake of centrally acting analgesics * known severe acute or chronic disorder, that do not allow participation in the therapy * other known diseases, that do not allow participation in the therapy * known alcohol or substance abuse * no sufficient German language skills * current application for a benefit * participation in another clinical trial during six months before the study and parallel to the study * conducting regular relaxation techniques, mindfulness training or meditation six weeks before the study or planned in the next 6 months

Design outcomes

Primary

MeasureTime frame
Primary outcome is the mean pain intensity over 3 months measured by the daily pain intensity on the Numeric rating scale (NRS)3 months

Secondary

MeasureTime frameDescription
Mean pain intensity measured weekly as the average pain intensity of the last seven days on a NRS3 and 6 months
Pain acceptance3 and 6 monthsGerman version of Chronic Pain Acceptance Questionnaire
Stress3 and 6 monthsNRS
Mean pain intensity measured by the daily pain intensity on the NRS6 months
Number of serious adverse event3 and 6 month
medication intake3 and 6 months
Number of sick leave days3 and 6 months
Suspected adverse reaction3 and 6 month

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026